DJIA 17,622.61 265.74 1.53%
NASDAQ 4,718.88 74.56 1.61%
S&P 500 2,044.42 31.53 1.57%
market minute promo

Novartis (NYSE: NVS)

94.06 1.77 (1.92%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $94.07 1.93%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $93.69
Previous Close $92.29
Daily Range $93.43 - $94.10
52-Week Range $76.60 - $96.97
Market Cap $227.5B
P/E Ratio 24.94
Dividend (Yield) $2.72 (2.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 206,744
Average Daily Volume 1,168,418
Current FY EPS $5.20





Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary Rss Feed

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

European Stocks Rise as German Business Confidence Jumps

Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog

Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog

Another Take On Why Timing The Market Does Not Work

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.

Benzinga's Top #PreMarket Gainers

3 Reasons GlaxoSmithKline PLC Could Soar in 2015

GlaxoSmithKline shareholders have suffered through a rough year, but these three catalysts could send its stock soaring in 2015.

US Stock Futures Edge Lower; Crude Oil Drops

Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson

Novartis AG and Amgen Inc. have promising new psoriasis drugs that could challenge Johnson & Johnson's Stelara for market share.

See More NVS News...

NVS's Top Competitors

NVS $94.06 (1.92%)
Current stock: NVS
JNJ $105.42 (1.30%)
Current stock: JNJ
MRK $58.58 (1.65%)
Current stock: MRK
GSK $43.09 (2.50%)
Current stock: GSK